ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Younger patients with lung cancer are more likely to have mutations that allow for targeted therapies, which can lead to more ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

7, 2025 — As many as one ... cells each day to keep the oxygen flowing. For many years, ... Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer ...

The Most Effective Prevention Method for Complications Post Lung Transplant Apr. 22, 2025 — When receiving a lung transplant, one of the most ... that boosts cancer cell metabolism to fuel ...

Teos and GSK were the last to report a new setback in TIGIT targeting for non-small cell lung cancer patients. Read why I am ...

Trastuzumab deruxtecan belongs to a group of antineoplastic drugs known as antibody-drug conjugates (ADCs). This type of ...

beating BeiGene’s PD-1 Tevimbra in their respective combinations with chemotherapy in first-line squamous non-small cell lung cancer on progression-free survival. To put the 22.3% overall ...